Supera Self-expanding Stents for Endovascular Treatment of Femoropopliteal Disease: The Clinical Evidence - George Adams, MD, MHS

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Supera Self-expanding Stents for Endovascular Treatment of Femoropopliteal Disease: The Clinical Evidence presented by George Adams, MD, MHS at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Vascular Surgeons
  • Interventional Radiologists
  • Interventional Fellows

Sponsored by Abbott Vascular

Session Name: Advantages and Indications for the Supera Stent (NON-CME)

Track: CRT 2016 Endovascular

Learning Objectives

Update in advances in endovascular procedures

Loading Simple Education